Institutional Research Archive

Hedge Fund Letters Archive

Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.

Quarter	Letter Date	Fund Name	QTD	YTD	Tickers	Themes	Quick Take

Home Letters Funds Account

Sequoia Fund 2025 Q3 Investor Letter | Buyside Digest

Back to Fund Profile (Sequoia Fund)

Primary Source Intelligence • Q3 2025 Letter Analysis

Sequoia Fund Quarterly Analysis

Buyside Digest is not affiliated with, and does not endorse, Sequoia Fund. This analysis is provided for institutional research purposes only and is not investment advice.

Fund Returns

QTD+16.3%

YTD+21.59%

Annualized+12.24%

Positioning StanceCONSTRUCTIVE

Market CapLarge Cap

Digest Analysis

Quick Take

"Underperforming the S&P 500 in the quarter but outperforming YTD. The fund trimmed Meta, Jacobs, Charles Schwab, and TSMC to fund an addition to Elevance Health and two undisclosed new positions."

Executive Summary

For the third quarter of 2025, Sequoia Fund generated a total return of 1.63% net of fees, underperforming the S&P 500 Index's return of 8.12%. On a year-to-date basis through September 30, 2025, the Fund generated a return of 21.59% net of fees, outperforming the Index's 14.83%. During the quarter, the investment committee reduced the Fund's exposure to Meta Platforms, Jacobs Engineering, Charles Schwab, and Taiwan Semiconductor. The proceeds from these sales were redeployed into a small addition in Elevance Health alongside initiating two new, undisclosed positions that will be revealed once purchases are completed.

Unlock Full Institutional Analysis

Sign in or create a free account to unlock full commentary, extracted equity pitches, and direct outbound manager source links with your 3 quarterly credits.

Institutional Meta Strategy

Meta Strategy Gauges

Algorithmic conviction, macroeconomic posture, and risk appetite signals extracted from this quarterly letter with qualitative explanations.

Signal Matrix

Market Conviction

88%

CautiousHigh

High Conviction (88%)

Assigned 0.88, reflecting very high portfolio concentration, with the top ten holdings accounting for nearly 70% of total assets. Notably, the largest holding, Rolls-Royce, comprises 17.3% of the portfolio, demonstrating extreme high-conviction position sizing.

Growth Outlook

50%

BearishBullish

Neutral (50%)

Assigned 0.50 because the brief quarterly letter does not address broader stock market conditions or macroeconomic outlooks, focusing exclusively on performance and transaction activity.

Risk Appetite

70%

DefensiveAggressive

Balanced (70%)

Assigned 0.70 as the fund maintains a highly concentrated, long-only equity portfolio. Recent actions show them actively recycling capital from trimmed positions into new long opportunities and adding to existing holdings.

Capital Deployment

50%

De-riskingDeploying

Net Neutral (50%)

Assigned 0.50 since the fund trimmed four existing positions specifically to fund a small addition to Elevance Health and two new investments, indicating a balanced capital recycling action with neutral net cash flow.

Forward Guidance

75%

CautiousExpansionary

Expansionary (75%)

Assigned 0.75 due to active purchasing behavior, with the fund actively deploying capital into two new undisclosed investments and an addition to Elevance Health.

Language Signal

50%

BearishBullish

Balanced (50%)

Assigned 0.50 as the letter is purely descriptive and regulatory, reporting performance and transactions without relying on emotionally charged bullish or bearish vocabulary.

Perceived Risk

35%

Low RiskElevated

Moderate Risk (35%)

Assigned 0.35 because the letter does not discuss macro or environmental risks, only providing standard regulatory disclosures regarding the risks of a non-diversified fund structure.

Opportunity Density

60%

ScarceAbundant

Selective (60%)

Assigned 0.60 as the fund has successfully identified and initiated two new investments during the quarter alongside an addition to an existing holding, demonstrating a healthy pipeline of selective opportunities.

Time Horizon

70%

Short-TermLong-Term

Decade+ (70%)

Assigned 0.70 to reflect the multi-year compounder approach typically associated with Sequoia's investment style and holdings, though the brief letter does not explicitly define their current holding period expectations.